TPNIES approval to provide additional reimbursement for Tablo home dialysis treatments
Outset Medical, Inc. (Nasdaq: OM) ("Outset") today announced that its Tablo® Hemodialysis System has received the first-ever approval from the Centers for Medicare & Medicaid Services (CMS) for a Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES). This pioneering decision will help encourage healthcare providers to embrace new technology enabling more patients to dialyze at home and reclaim their independence.
https://finance.yahoo.com/news/outset-medical-tablo-hemodialysis-system-120300770.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.